Sexual Dysfunction Disorder. Other sexual dysfunction not due to a substance or known physiological condition
Conditions
Interventions
Intervention 1: Intervention group: Tablets containing 3 mg of melatonin daily (once daily) and SSRIs and Buspirone for 8 weeks. Intervention 2: Control group: Placebo tablets with the appearance of m
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women with depression diagnosed with SSRIs-induced sexual dysfunction Age range 20 to 50 years Patient consent to participate in the study Absence of a bleeding disorder or blood clot such as hemophilia Do not take blood thinners such as warfarin Do not HTN or hypotention Absence of epilepsy or other seizure disorders Do not use drugs to prevent organ transplant rejection Absence of an autoimmune disease Absence of pregnancy and lactation Not Hypersensitivity to melatonin and its derivatives No history of sexual dysfunction Addiction to opium Do not take supplements to improve sexual function
Exclusion criteria
Exclusion criteria: The patient is in menopause Lack of complete cooperation of the patient regarding the use of melatonin or the occurrence of a side effect that should result in discontinuation of melatonin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Individual score on the Arizona Sexual Experience Questionnaire. Timepoint: Before the intervention and after the end of the study. Method of measurement: Arizona Sexual Experience Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahboubeh Eslamzadeh
Mashhad University of Medical Sciences
Outcome results
None listed